Companies: 11,114     total market cap: โ‚น14499.040 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Palatin Technologies
PTN
#10642
Rank
โ‚น1.39 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น782.11
Share price
-6.03%
Change (1 day)
N/A
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Revenue for Palatin Technologies (PTN)

Revenue in 2026 (TTM): โ‚น1.16 Billion

According to Palatin Technologies's latest financial reports the company's current revenue (TTM ) is โ‚น1.24 Billion. In 2025 the company made a revenue of โ‚น0.80 Billion an increase over the revenue in the year 2024 that were of โ‚น30.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Palatin Technologies from 1998 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น1.16 B44.53%
2025 โ‚น0.80 B2579.92%
2024 โ‚น30.02 M-94.92%
2023 โ‚น0.59 B147.68%
2022 โ‚น0.23 B329.9%
2021 โ‚น55.49 M-267.67%
2020 -โ‚น33.1 Million-100.77%
2019 โ‚น4.30 B107.94%
2018 โ‚น2.07 B-60.58%
2017 โ‚น5.25 B
2016 N/A
2015 N/A-100%
2014 โ‚น0.82 B
2013 N/A-100%
2012 โ‚น2.48 M-81.64%
2011 โ‚น13.53 M-93.28%
2010 โ‚น0.20 B-78.66%
2009 โ‚น0.94 B426.51%
2008 โ‚น0.17 B-70.44%
2007 โ‚น0.60 B-26.78%
2006 โ‚น0.82 B0.1%
2005 โ‚น0.82 B101.14%
2004 โ‚น0.41 B256.04%
2003 โ‚น0.11 B128.32%
2002 โ‚น50.59 M166.65%
2001 โ‚น18.97 M-89.52%
2000 โ‚น0.18 B45.55%
1999 โ‚น0.12 B265.51%
1998 โ‚น34.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.304 T 747,804.75%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.835 T 468,991.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น299.55 B 23,978.99%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
โ‚น57.6 M-95.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น26.50 B 2,030.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น18.62 B 1,396.79%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น89.18 B 7,069.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น41.29 B 3,219.39%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com